Cargando…

Changes in Body Image in Patients with Prostate Cancer over 2 Years of Treatment with a Gonadotropin-Releasing Hormone Analogue (Triptorelin): Results from a Belgian Non-Interventional Study

BACKGROUND: Androgen deprivation therapy has been associated with worsened body image in prostate cancer patients. Body image and physical presentation changes were investigated in patients receiving a gonadotropin-releasing hormone analogue (triptorelin) as part of treatment for locally advanced or...

Descripción completa

Detalles Bibliográficos
Autores principales: van den Driessche, Hans, Mattelaer, Pieter, van Oyen, Peter, Marchand, Wouter, Bar-Moshé, Ovadia, Merckx, Luc, Billiet, Ignace, Cabri, Patrick, Maisonobe, Pascal, De Ruyter, Vincent, Braeckman, Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914546/
https://www.ncbi.nlm.nih.gov/pubmed/27398297
http://dx.doi.org/10.1007/s40801-016-0074-5
_version_ 1782438569450668032
author van den Driessche, Hans
Mattelaer, Pieter
van Oyen, Peter
Marchand, Wouter
Bar-Moshé, Ovadia
Merckx, Luc
Billiet, Ignace
Cabri, Patrick
Maisonobe, Pascal
De Ruyter, Vincent
Braeckman, Johan
author_facet van den Driessche, Hans
Mattelaer, Pieter
van Oyen, Peter
Marchand, Wouter
Bar-Moshé, Ovadia
Merckx, Luc
Billiet, Ignace
Cabri, Patrick
Maisonobe, Pascal
De Ruyter, Vincent
Braeckman, Johan
author_sort van den Driessche, Hans
collection PubMed
description BACKGROUND: Androgen deprivation therapy has been associated with worsened body image in prostate cancer patients. Body image and physical presentation changes were investigated in patients receiving a gonadotropin-releasing hormone analogue (triptorelin) as part of treatment for locally advanced or metastatic prostate cancer. OBJECTIVE: The aim was to evaluate the changes in self-perception of the body and to assess the relationship of these changes over a period of 2 years in men treated with triptorelin as primary therapy for advanced or locally advanced prostate cancer. METHODS: Data were collected for 2 years in accordance with routine clinical practice. Body image was assessed using the body image scale (BIS). Patient body mass index (BMI) and waist circumference were also measured. RESULTS: BIS and BMI data for both baseline and a least one post-baseline visit were available for 98 of the 145 patients enrolled. The median change in BIS score for patients assessed around 12 or 24 months after baseline and at the last observation was zero, indicating no body image deterioration in at least half of patients. Statistically significant BIS score increases were detected in assessments around 6, 12 and 18 months, but not after 2 years, indicating some patients experienced body image deterioration at some point during treatment. Changes in BMI from baseline were modest and generally not statistically significant. Waist circumference increased during the study (mean ± standard deviation increase of 1.00 ± 5.01 cm at the last observation). Positive correlations were determined between increases in BIS score and both BMI and waist circumference (r = 0.235 and 0.267, respectively; p = 0.020 and 0.008) at the last observation for all patients, as well as during the second year of the study. CONCLUSIONS: Most patients did not experience clinically meaningful worsening of body image perception during the study. BMI and waist circumference had a modest impact on body image during study year 2.
format Online
Article
Text
id pubmed-4914546
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-49145462016-07-06 Changes in Body Image in Patients with Prostate Cancer over 2 Years of Treatment with a Gonadotropin-Releasing Hormone Analogue (Triptorelin): Results from a Belgian Non-Interventional Study van den Driessche, Hans Mattelaer, Pieter van Oyen, Peter Marchand, Wouter Bar-Moshé, Ovadia Merckx, Luc Billiet, Ignace Cabri, Patrick Maisonobe, Pascal De Ruyter, Vincent Braeckman, Johan Drugs Real World Outcomes Original Research Article BACKGROUND: Androgen deprivation therapy has been associated with worsened body image in prostate cancer patients. Body image and physical presentation changes were investigated in patients receiving a gonadotropin-releasing hormone analogue (triptorelin) as part of treatment for locally advanced or metastatic prostate cancer. OBJECTIVE: The aim was to evaluate the changes in self-perception of the body and to assess the relationship of these changes over a period of 2 years in men treated with triptorelin as primary therapy for advanced or locally advanced prostate cancer. METHODS: Data were collected for 2 years in accordance with routine clinical practice. Body image was assessed using the body image scale (BIS). Patient body mass index (BMI) and waist circumference were also measured. RESULTS: BIS and BMI data for both baseline and a least one post-baseline visit were available for 98 of the 145 patients enrolled. The median change in BIS score for patients assessed around 12 or 24 months after baseline and at the last observation was zero, indicating no body image deterioration in at least half of patients. Statistically significant BIS score increases were detected in assessments around 6, 12 and 18 months, but not after 2 years, indicating some patients experienced body image deterioration at some point during treatment. Changes in BMI from baseline were modest and generally not statistically significant. Waist circumference increased during the study (mean ± standard deviation increase of 1.00 ± 5.01 cm at the last observation). Positive correlations were determined between increases in BIS score and both BMI and waist circumference (r = 0.235 and 0.267, respectively; p = 0.020 and 0.008) at the last observation for all patients, as well as during the second year of the study. CONCLUSIONS: Most patients did not experience clinically meaningful worsening of body image perception during the study. BMI and waist circumference had a modest impact on body image during study year 2. Springer International Publishing 2016-05-13 /pmc/articles/PMC4914546/ /pubmed/27398297 http://dx.doi.org/10.1007/s40801-016-0074-5 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Research Article
van den Driessche, Hans
Mattelaer, Pieter
van Oyen, Peter
Marchand, Wouter
Bar-Moshé, Ovadia
Merckx, Luc
Billiet, Ignace
Cabri, Patrick
Maisonobe, Pascal
De Ruyter, Vincent
Braeckman, Johan
Changes in Body Image in Patients with Prostate Cancer over 2 Years of Treatment with a Gonadotropin-Releasing Hormone Analogue (Triptorelin): Results from a Belgian Non-Interventional Study
title Changes in Body Image in Patients with Prostate Cancer over 2 Years of Treatment with a Gonadotropin-Releasing Hormone Analogue (Triptorelin): Results from a Belgian Non-Interventional Study
title_full Changes in Body Image in Patients with Prostate Cancer over 2 Years of Treatment with a Gonadotropin-Releasing Hormone Analogue (Triptorelin): Results from a Belgian Non-Interventional Study
title_fullStr Changes in Body Image in Patients with Prostate Cancer over 2 Years of Treatment with a Gonadotropin-Releasing Hormone Analogue (Triptorelin): Results from a Belgian Non-Interventional Study
title_full_unstemmed Changes in Body Image in Patients with Prostate Cancer over 2 Years of Treatment with a Gonadotropin-Releasing Hormone Analogue (Triptorelin): Results from a Belgian Non-Interventional Study
title_short Changes in Body Image in Patients with Prostate Cancer over 2 Years of Treatment with a Gonadotropin-Releasing Hormone Analogue (Triptorelin): Results from a Belgian Non-Interventional Study
title_sort changes in body image in patients with prostate cancer over 2 years of treatment with a gonadotropin-releasing hormone analogue (triptorelin): results from a belgian non-interventional study
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914546/
https://www.ncbi.nlm.nih.gov/pubmed/27398297
http://dx.doi.org/10.1007/s40801-016-0074-5
work_keys_str_mv AT vandendriesschehans changesinbodyimageinpatientswithprostatecancerover2yearsoftreatmentwithagonadotropinreleasinghormoneanaloguetriptorelinresultsfromabelgiannoninterventionalstudy
AT mattelaerpieter changesinbodyimageinpatientswithprostatecancerover2yearsoftreatmentwithagonadotropinreleasinghormoneanaloguetriptorelinresultsfromabelgiannoninterventionalstudy
AT vanoyenpeter changesinbodyimageinpatientswithprostatecancerover2yearsoftreatmentwithagonadotropinreleasinghormoneanaloguetriptorelinresultsfromabelgiannoninterventionalstudy
AT marchandwouter changesinbodyimageinpatientswithprostatecancerover2yearsoftreatmentwithagonadotropinreleasinghormoneanaloguetriptorelinresultsfromabelgiannoninterventionalstudy
AT barmosheovadia changesinbodyimageinpatientswithprostatecancerover2yearsoftreatmentwithagonadotropinreleasinghormoneanaloguetriptorelinresultsfromabelgiannoninterventionalstudy
AT merckxluc changesinbodyimageinpatientswithprostatecancerover2yearsoftreatmentwithagonadotropinreleasinghormoneanaloguetriptorelinresultsfromabelgiannoninterventionalstudy
AT billietignace changesinbodyimageinpatientswithprostatecancerover2yearsoftreatmentwithagonadotropinreleasinghormoneanaloguetriptorelinresultsfromabelgiannoninterventionalstudy
AT cabripatrick changesinbodyimageinpatientswithprostatecancerover2yearsoftreatmentwithagonadotropinreleasinghormoneanaloguetriptorelinresultsfromabelgiannoninterventionalstudy
AT maisonobepascal changesinbodyimageinpatientswithprostatecancerover2yearsoftreatmentwithagonadotropinreleasinghormoneanaloguetriptorelinresultsfromabelgiannoninterventionalstudy
AT deruytervincent changesinbodyimageinpatientswithprostatecancerover2yearsoftreatmentwithagonadotropinreleasinghormoneanaloguetriptorelinresultsfromabelgiannoninterventionalstudy
AT braeckmanjohan changesinbodyimageinpatientswithprostatecancerover2yearsoftreatmentwithagonadotropinreleasinghormoneanaloguetriptorelinresultsfromabelgiannoninterventionalstudy